Total Payments
$3,857
2024 Payments
$305.83
Companies
18
Transactions
166
Medicare Patients
1,697
Medicare Billing
$296,348
Payment Breakdown by Category
Food & Beverage$3,736 (96.9%)
Other$119.93 (3.1%)
Education$1.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,736 | 164 | 96.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $119.93 | 1 | 3.1% |
| Education | $1.21 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,794 | 87 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $440.50 | 32 | $0 (2019) |
| Neuronetics, Inc. | $398.44 | 8 | $0 (2017) |
| Indivior Inc. | $309.44 | 6 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $126.73 | 1 | $0 (2024) |
| UCB, Inc. | $124.95 | 2 | $0 (2019) |
| Amgen Inc. | $124.85 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $124.21 | 11 | $0 (2024) |
| Adamas Pharmaceuticals, Inc. | $91.48 | 1 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $66.16 | 4 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $305.83 | 12 | Neurocrine Biosciences, Inc. ($126.73) |
| 2023 | $462.42 | 24 | ABBVIE INC. ($462.42) |
| 2022 | $1,058 | 47 | ABBVIE INC. ($1,058) |
| 2021 | $186.27 | 10 | AbbVie Inc. ($186.27) |
| 2019 | $588.89 | 19 | UCB, Inc. ($124.95) |
| 2018 | $333.51 | 20 | Adamas Pharmaceuticals, Inc. ($91.48) |
| 2017 | $922.46 | 34 | Neuronetics, Inc. ($398.44) |
All Payment Transactions
166 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $18.24 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: NEUROSCIENCE | ||||||
| 05/31/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: OUD | ||||||
| 03/07/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $126.73 | General |
| Category: Neuropsychiatry | ||||||
| 02/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 409 | 982 | $126,875 | $67,986 |
| 2022 | 3 | 450 | 1,169 | $147,315 | $83,792 |
| 2021 | 3 | 428 | 1,117 | $137,760 | $80,464 |
| 2020 | 3 | 410 | 1,095 | $135,190 | $64,106 |
Total Patients
1,697
Total Services
4,363
Medicare Billing
$296,348
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 245 | 783 | $86,535 | $49,116 | 56.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 96 | 96 | $28,625 | $12,937 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 103 | $11,715 | $5,933 | 50.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 266 | 939 | $98,595 | $59,861 | 60.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 126 | 127 | $37,905 | $18,243 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 103 | $10,815 | $5,688 | 52.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 263 | 908 | $95,340 | $59,559 | 62.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 104 | 105 | $31,500 | $15,015 | 47.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 104 | $10,920 | $5,890 | 53.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 293 | 978 | $102,670 | $52,284 | 50.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 105 | 105 | $31,500 | $11,620 | 36.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 12 | $1,020 | $202.72 | 19.9% |
About Dr. David Kroessler, MD
Dr. David Kroessler, MD is a Psychiatry healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740211168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kroessler, MD has received a total of $3,857 in payments from pharmaceutical and medical device companies, with $305.83 received in 2024. These payments were reported across 166 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($3,736).
As a Medicare-enrolled provider, Kroessler has provided services to 1,697 Medicare beneficiaries, totaling 4,363 services with total Medicare billing of $296,348. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Warwick, RI
- Active Since 07/05/2006
- Last Updated 09/23/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1740211168
Products in Payments
- VRAYLAR (Drug) $1,766
- LATUDA (Drug) $440.50
- NeuroStar TMS Therapy (Device) $398.44
- Trintellix (Drug) $176.08
- SUBLOCADE (Drug) $169.69
- SUBOXONE SUBLINGUAL FILM (Drug) $139.75
- INGREZZA (Drug) $126.73
- Neupro (Drug) $124.95
- Aimovig (Biological) $124.85
- GOCOVRI (Drug) $91.48
- NUEDEXTA (Drug) $46.80
- REXULTI (Drug) $42.71
- Vivitrol 380 mg (Drug) $38.59
- SPRAVATO (Drug) $37.73
- QULIPTA (Drug) $24.79
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $23.47
- INVEGA TRINZA (Drug) $21.43
- COBENFY (Drug) $18.24
- Zubsolv (Drug) $16.38
- TRINTELLIX (Drug) $14.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Warwick
Warren Ong, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Ethan Kisch, M.d, M.D
Psychiatry — Payments: $74,541
Psychiatry $74,541
Dr. Terrie Mailhot, Md, MD
Psychiatry — Payments: $29,075
Psychiatry $29,075
Charles Denby, Md, MD
Psychiatry — Payments: $5,968
Psychiatry $5,968
James Gallo, Md, MD
Psychiatry — Payments: $5,708
Psychiatry $5,708
Dr. Alexander Scagnelli, M.d, M.D
Psychiatry — Payments: $2,626
Psychiatry $2,626